VOCAL Trademark

Trademark Overview


On Wednesday, November 4, 2020, a trademark application was filed for VOCAL with the United States Patent and Trademark Office. The USPTO has given the VOCAL trademark a serial number of 90299534. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Sunday, February 25, 2024. This trademark is owned by Aurinia Pharmaceuticals Inc.. The VOCAL trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Promoting and raising the awareness of lupus nephritis namely, by organizing, conducting and presentation of seminars in the field of lupus nephritis for the public, medical professionals, and patients

Promoting public awareness of lupus nephritis

Medical information services, namely, reporting results of consumer authorized clinical testing results directly to patients; clinical medical practice consultation in the field of lupus nephritis

Medical research and development in the field of lupus nephritis; conducting clinical trials for others in the field of lupus nephritis

General Information


Serial Number90299534
Word MarkVOCAL
Filing DateWednesday, November 4, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateSunday, February 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPromoting and raising the awareness of lupus nephritis namely, by organizing, conducting and presentation of seminars in the field of lupus nephritis for the public, medical professionals, and patients
Goods and ServicesPromoting public awareness of lupus nephritis
Goods and ServicesMedical information services, namely, reporting results of consumer authorized clinical testing results directly to patients; clinical medical practice consultation in the field of lupus nephritis
Goods and ServicesMedical research and development in the field of lupus nephritis; conducting clinical trials for others in the field of lupus nephritis

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, August 3, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, January 5, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 3, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAurinia Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressVictoria, BC V8Z7X8
CA

Trademark Events


Event DateEvent Description
Sunday, February 25, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, February 25, 2024LETTER OF SUSPENSION E-MAILED
Sunday, February 25, 2024SUSPENSION LETTER WRITTEN
Saturday, January 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 4, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, October 15, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sunday, October 15, 2023INQUIRY TO SUSPENSION E-MAILED
Sunday, October 15, 2023SUSPENSION INQUIRY WRITTEN
Wednesday, September 6, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, February 11, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, February 11, 2023LETTER OF SUSPENSION E-MAILED
Saturday, February 11, 2023SUSPENSION LETTER WRITTEN
Saturday, January 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 7, 2023ASSIGNED TO LIE
Thursday, November 10, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, May 11, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 10, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, May 10, 2022INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 10, 2022SUSPENSION INQUIRY WRITTEN
Sunday, September 19, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, September 19, 2021LETTER OF SUSPENSION E-MAILED
Sunday, September 19, 2021SUSPENSION LETTER WRITTEN
Tuesday, August 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 19, 2021NON-FINAL ACTION E-MAILED
Friday, February 19, 2021NON-FINAL ACTION WRITTEN
Friday, February 19, 2021ASSIGNED TO EXAMINER
Tuesday, January 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 7, 2020NEW APPLICATION ENTERED